[LAUREN TAYLOR]

THE UNITED STATES GOVERNMENT IS WORKING TO FUND A BIRD FLU HUMAN VACCINE TRIAL FOR MODERNA – ACCORDING TO A REPORT BY THE FINANCIAL TIMES.

RIGHT NOW – H5N1 BIRD FLU IS SPREADING AMONG WILD BIRDS – CAUSING OUTBREAKS IN POULTRY AND DAIRY COWS.

THE USDA HAS ALSO DETECTED THE VIRUS IN OUR NATION’S MILK SUPPLY.

ON APRIL 24TH – THE USDA ANNOUNCED A FEDERAL ORDER REQUIRING LACTATING DAIRY COWS BE TESTED PRIOR TO INTERSTATE MOVEMENT – ANNOUNCING FINANCIAL ASSISTANCE FOR PRODUCERS WITH AFFECTED HERDS.  

JUST THIS WEEK – IOWA GOVERNOR KIM REYNOLDS ISSUED A DISASTER PROCLAMATION FOR SIOUX COUNTY, IOWA – AFTER IT WAS REVEALED THAT MORE THAN 4-MILLION CHICKENS WOULD HAVE TO BE KILLED AFTER A BIRD FLU OUTBREAK AT A FARM.

AND TWO DAIRY WORKERS –ONE IN TEXAS AND ONE IN MICHIGAN– CONTRACTED THE VIRUS IN THE LAST TWO MONTHS – HOWEVER, THEY’VE SINCE BOTH RECOVERED AND THE CENTERS FOR DISEASE CONTROL SAYS THE CURRENT PUBLIC HEALTH RISK IS “LOW”.

SCIENTISTS SAY BIRD FLU IS UNLIKELY TO BECOME THE NEXT PANDEMIC – BECAUSE RIGHT NOW – H5N1 DOESN’T TRANSMIT EFFECTIVELY FROM PERSON-TO-PERSON LIKE WE SEE WITH COVID-19. 

SO WHY WOULD PHARMACEUTICAL COMPANIES NEED TO PRODUCE MORE DOSES OF A BIRD FLU PANDEMIC VACCINE?

WELL, THE SCIENTISTS DO SAY THERE’S REASON TO BE CAUTIOUS – BUT NOT TO PANIC.

CURRENTLY, THE FEDERAL GOVERNMENT HAS A STOCKPILE OF  A VACCINE THAT COULD BE USED TO HELP PREVENT H5N1 IN HUMANS – “IN THE EVENT THAT THE H5N1 AVIAN INFLUENZA VIRUS DEVELOPS THE CAPABILITY TO SPREAD EFFICIENTLY FROM PERSON-TO-PERSON RESULTING IN THE RAPID SPREAD OF DISEASE ACROSS THE GLOBE.”

RIGHT NOW – THE UNITED STATES AND EUROPEAN NATIONS ARE LOOKING TO VACCINATE FRONT LINE WORKERS – SUCH AS POULTRY FARMERS AND DAIRY FARM WORKERS WHO COULD BE EXPOSED TO BIRD FLU.

ACCORDING TO DAVID BOUCHER – THE DIRECTOR OF INFECTIOUS DISEASE AT THE DEPARTMENT OF HEALTH AND HUMAN SERVICES – THE EFFECTIVENESS OF THE CURRENT BIRD FLU VACCINE IS LOW SINCE IT’S NOT A PERFECT MATCH AGAINST THE CIRCULATING STRAIN.

SCIENTISTS SAY THEY’RE LOOKING to develop a HUMAN MRNA BIRD FLU VACCINE BECAUSE those vaccines CAN BE RAPIDLY PRODUCED AND TAILORED TO THE CIRCULATING STRAIN OF THE VIRUS.

THE FINANCIAL TIMES REPORTS: “SEVERAL TENS OF MILLIONS OF DOLLARS” WORTH OF FEDERAL FUNDING COULD COME FROM THE BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY SOMETIME NEXT MONTH TO FUND A LATE-STAGE TRIAL FOR AN MODERNA MRNA BIRD FLU VACCINE.

ACCORDING TO THE ALLEGED DEAL – BARDA WOULD ALSO PURCHASE A STOCKPILE OF DOSES OF THE VACCINE IF THE TRIALS PROVE SUCCESSFUL.

IT’S ALSO EXPECTED THAT MODERNA WILL RELEASE INTERIM TRIAL DATA “SOON.”

FOR STRAIGHT ARROW NEWS, I’M LT.

STAY UP TO DATE ON THE NEWS OF THE DAY AND DOWNLOAD THE STRAIGHT ARROW NEWS APP OR VISIT SAN DOT COM.